Guijiang Wang

Title: Guijiang Wang: Innovator in Pharmaceutical Composition

Introduction

Guijiang Wang is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.

Latest Patents

Wang holds a patent for a composition comprising aflibercept and a variant thereof. This invention includes a truncation variant with a truncated VEGF binding portion of aflibercept, where the content of the truncation variant is less than or equal to about 20% by mass percentage. Additionally, the patent outlines a pharmaceutical formulation that incorporates this composition. It also provides methods for detecting the variant and its use in quality inspection or quality control of aflibercept-containing products. Wang's innovative work is encapsulated in his 1 patent.

Career Highlights

Guijiang Wang is associated with Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His role at the company has allowed him to focus on research and development, contributing to advancements in drug formulations and therapeutic applications.

Collaborations

Wang has collaborated with notable colleagues, including Yue Yu and Jiulin Wang. These partnerships have fostered a collaborative environment that enhances the innovation process within their projects.

Conclusion

Guijiang Wang's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patent reflects the potential for improved therapeutic options in the healthcare industry.